Trial Profile
A Multi-Centre, Open Label, Randomized, Parallel Group Pilot Study to Assess the Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2021
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary) ; Sevelamer
- Indications Hyperphosphataemia
- Focus Therapeutic Use
- Sponsors Shire; Shire Pharmaceutical Development
- 17 Jun 2014 New trial record